Patent · US Active

Serine/threonine kinase inhibitors

US10517878B2 · kind B2 · utility

2Cited by

3References

13Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Aleksandr Kolesnikov · Mill Valley, US
Steven Do · San Jose, US

Key dates

Filing date	Feb 27, 2019
Grant date	Dec 31, 2019
Priority date	—
Expiry date	Feb 27, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds having the formula I wherein R1, X1, X2, X3 and X4 as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.